Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Rebound of disease activity after fingolimod withdrawal: Immunological and gene expression profiling.

Sacco R, Emming S, Gobbi C, Zecca C, Monticelli S.

Mult Scler Relat Disord. 2020 Jan 3;40:101927. doi: 10.1016/j.msard.2020.101927. [Epub ahead of print]

PMID:
31931457
2.

Neurologic complications of acute hepatitis E virus infection.

Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C.

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 5;7(1). pii: e643. doi: 10.1212/NXI.0000000000000643. Print 2020 Jan.

3.

Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period?

Sacco R, Disanto G, Maraffi I, Candrian U, Kamm CP, Rossi S, Schwegler G, Gallo A, Gobbi C, Zecca C.

Mult Scler Relat Disord. 2019 Nov 12;38:101523. doi: 10.1016/j.msard.2019.101523. [Epub ahead of print]

PMID:
31743848
4.

Framing multiple sclerosis under a polysomnographic perspective.

Tanioka K, Castelnovo A, Tachibana N, Miano S, Zecca C, Gobbi C, Manconi M.

Sleep. 2019 Oct 22. pii: zsz232. doi: 10.1093/sleep/zsz232. [Epub ahead of print]

PMID:
31637431
5.

Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.

Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira À, Montalban X, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Gass A, Eisele P, Lukas C, Bellenberg B, Barkhof F, Vrenken H, Preziosa P, Comi G, Filippi M; MAGNIMS Study Group.

Neurology. 2019 Nov 12;93(20):e1852-e1866. doi: 10.1212/WNL.0000000000008466. Epub 2019 Oct 14.

PMID:
31611336
6.

Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.

Kamm CP, Barin L, Gobbi C, Pot C, Calabrese P, Salmen A, Achtnichts L, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR).

J Neurol. 2020 Jan;267(1):153-161. doi: 10.1007/s00415-019-09563-y. Epub 2019 Oct 8.

PMID:
31595377
7.

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

Zecca C, Bovis F, Novi G, Capobianco M, Lanzillo R, Frau J, Repice AM, Hakiki B, Realmuto S, Bonavita S, Curti E, Brambilla L, Mataluni G, Cavalla P, Di Sapio A, Signoriello E, Barone S, Maniscalco GT, Maietta I, Maraffi I, Boffa G, Malucchi S, Nozzolillo A, Coghe G, Mechi C, Salemi G, Gallo A, Sacco R, Cellerino M, Malentacchi M, De Angelis M, Lorefice L, Magnani E, Prestipino E, Sperli F, Brescia Morra V, Fenu G, Barilaro A, Abbadessa G, Signori A, Granella F, Amato MP, Uccelli A, Gobbi C, Sormani MP.

Mult Scler. 2019 Oct 1:1352458519872889. doi: 10.1177/1352458519872889. [Epub ahead of print]

PMID:
31573386
8.

Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis.

Gobbi CA, Asbert P, Alba PB, Resk J, Dotto G, Demarchi M, Cuvertino E, Pepe GA, Salica DA, Albiero EH, Martínez F.

Rev Fac Cien Med Univ Nac Cordoba. 2019 Aug 29;76(3):174-179. doi: 10.31053/1853.0605.v76.n3.21610. Spanish.

PMID:
31465186
9.

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.

Barin L, Kamm CP, Salmen A, Dressel H, Calabrese P, Pot C, Schippling S, Gobbi C, Müller S, Chan A, Rodgers S, Kaufmann M, Ajdacic-Gross V, Steinemann N, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry.

Mult Scler. 2019 Jan 18:1352458518823955. doi: 10.1177/1352458518823955. [Epub ahead of print]

10.

Relapsing piriformis syndrome treated with botulinum toxin injections.

Ripellino P, Cianfoni A, Izzo MGA, Gobbi C.

BMJ Case Rep. 2019 Aug 9;12(8). pii: e230981. doi: 10.1136/bcr-2019-230981. No abstract available.

PMID:
31401586
11.

Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.

Disanto G, Prosperetti C, Gobbi C, Barro C, Michalak Z, Cassina T, Kuhle J, Casso G, Agazzi P.

Epilepsy Behav. 2019 Dec;101(Pt B):106432. doi: 10.1016/j.yebeh.2019.07.033. Epub 2019 Jul 30.

PMID:
31375414
12.

Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis.

Pravatà E, Valsasina P, Gobbi C, Zecca C, Riccitelli GC, Filippi M, Rocca MA.

Mult Scler. 2019 Jul 26:1352458519865989. doi: 10.1177/1352458519865989. [Epub ahead of print]

PMID:
31347448
13.

Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients.

Zecca C, Disanto G, Sacco R, Riccitelli GC, Gobbi C.

BMC Neurol. 2019 Jul 12;19(1):159. doi: 10.1186/s12883-019-1383-6.

14.

Efficiency in the environmental management of plastic wastes at Brazilian ports based on data envelopment analysis.

Gobbi CN, Sanches VML, Guimarães MJOC, Freitas MAV, Pacheco EBAV.

Mar Pollut Bull. 2019 May;142:377-383. doi: 10.1016/j.marpolbul.2019.03.061. Epub 2019 Apr 4.

PMID:
31232315
15.

Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study.

Zecca C, Pavelek Z, Přikrylová K, Ghielmetti M, Beeler A, Gobbi C.

Mult Scler Relat Disord. 2019 May;30:104-109. doi: 10.1016/j.msard.2019.02.010. Epub 2019 Feb 6.

PMID:
30763907
16.

Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis.

Naegelin Y, Naegelin P, von Felten S, Lorscheider J, Sonder J, Uitdehaag BMJ, Scotti B, Zecca C, Gobbi C, Kappos L, Derfuss T.

JAMA Neurol. 2019 Mar 1;76(3):274-281. doi: 10.1001/jamaneurol.2018.4239.

17.

Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland.

Kaufmann M, Kuhle J, Puhan MA, Kamm CP, Chan A, Salmen A, Kesselring J, Calabrese P, Gobbi C, Pot C, Steinemann N, Rodgers S, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR).

Mult Scler J Exp Transl Clin. 2018 Dec 6;4(4):2055217318814562. doi: 10.1177/2055217318814562. eCollection 2018 Oct-Dec.

18.

Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study.

Barin L, Kaufmann M, Salmen A, Kamm CP, Gobbi C, Kuhle J, Pot C, Chan A, Czaplinski A, Ajdacic-Gross V, Rodgers S, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry.

Mult Scler Relat Disord. 2019 Feb;28:17-25. doi: 10.1016/j.msard.2018.11.033. Epub 2018 Dec 2.

PMID:
30530118
19.

Relapsing paralytic ileus in multiple sclerosis requiring surgery: a video case report.

Chiaro G, Fratila C, Martig F, Zecca C, Gobbi C.

Clin Auton Res. 2019 Jun;29(3):349-351. doi: 10.1007/s10286-018-0573-4. Epub 2018 Nov 10. No abstract available.

PMID:
30415400
20.

Can Sleep Problems Have a Negative Impact on Falls in Older People?

Morelhão PK, Pinto RZ, Gobbi C, Tufik S, Andersen ML.

J Clin Sleep Med. 2018 Oct 15;14(10):1821-1822. doi: 10.5664/jcsm.7418. No abstract available.

21.

Autoimmune liver disease serology in acute hepatitis E virus infection.

Terziroli Beretta-Piccoli B, Ripellino P, Gobbi C, Cerny A, Baserga A, Di Bartolomeo C, Bihl F, Deleonardi G, Melidona L, Grondona AG, Mieli-Vergani G, Vergani D, Muratori L; Swiss Autoimmune Hepatitis Cohort Study Group.

J Autoimmun. 2018 Nov;94:1-6. doi: 10.1016/j.jaut.2018.07.006. Epub 2018 Jul 7.

PMID:
30336842
22.

The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?

Barin L, Salmen A, Disanto G, Babačić H, Calabrese P, Chan A, Kamm CP, Kesselring J, Kuhle J, Gobbi C, Pot C, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR).

Mult Scler Relat Disord. 2018 Oct;25:112-121. doi: 10.1016/j.msard.2018.07.013. Epub 2018 Jul 21.

PMID:
30059895
23.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

24.

Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?

Zecca C, Bellavia G, Brambilla L, Gutierrez LP, Gerardi C, Fiori AM, Bernardini LR, Camera G, Disanto G, Petrini L, Perugini J, Antozzi CG, Torri Clerici V, Bellino A, Confalonieri PA, Gobbi C, Mantegazza RE, Rossi S.

CNS Drugs. 2018 Jul;32(7):653-660. doi: 10.1007/s40263-018-0529-1.

PMID:
29949101
25.

[Lipid profile in early arthritis and its relation with inflammatory activity]

Gobbi CA, Asbert P, Alba PB, Alessio D, Subils G, Dotto G, Demarchi M, Albiero EH, Salica DA, Martínez F.

Rev Fac Cien Med Univ Nac Cordoba. 2017 Sep 8;74(3):256-262. Spanish.

PMID:
29890101
26.

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J.

Brain. 2018 Aug 1;141(8):2382-2391. doi: 10.1093/brain/awy154.

PMID:
29860296
27.

Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland.

Scotti B, Disanto G, Sacco R, Guigli M, Zecca C, Gobbi C.

PLoS One. 2018 May 14;13(5):e0197415. doi: 10.1371/journal.pone.0197415. eCollection 2018.

28.

Prodromal symptoms of multiple sclerosis in primary care.

Disanto G, Zecca C, MacLachlan S, Sacco R, Handunnetthi L, Meier UC, Simpson A, McDonald L, Rossi A, Benkert P, Kuhle J, Ramagopalan SV, Gobbi C.

Ann Neurol. 2018 Jun;83(6):1162-1173. doi: 10.1002/ana.25247. Epub 2018 May 30.

PMID:
29740872
29.

Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuation.

Zecca C, Antozzi CG, Torri Clerici V, Ferrazzini M, Mantegazza RE, Rossi S, Gobbi C.

Acta Neurol Scand. 2018 Jun;137(6):623-625. doi: 10.1111/ane.12882. Epub 2017 Dec 3. Review.

PMID:
29205270
30.

Physical Activity-Based Interventions Using Electronic Feedback May Be Ineffective in Reducing Pain and Disability in Patients With Chronic Musculoskeletal Pain: A Systematic Review With Meta-Analysis.

Oliveira CB, Franco MR, Maher CG, Ferreira PH, Morelhão PK, Damato TM, Gobbi C, Pinto RZ.

Arch Phys Med Rehabil. 2018 Sep;99(9):1900-1912. doi: 10.1016/j.apmr.2017.10.013. Epub 2017 Nov 6.

PMID:
29122581
31.

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study.

Zecca C, Disanto G, Mühl S, Gobbi C.

BMC Neurol. 2017 Sep 4;17(1):171. doi: 10.1186/s12883-017-0952-9.

32.

Primary Sjögren's syndrome and pregnancy: A report of 18 cases.

Demarchi J, Papasidero SB, Klajn D, Alba P, Babini AM, Durigan V, Gobbi C, Raiti L.

Reumatol Clin. 2019 Mar - Apr;15(2):109-112. doi: 10.1016/j.reuma.2017.07.014. Epub 2017 Aug 26. English, Spanish.

33.

Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.

van Eijk JJJ, Dalton HR, Ripellino P, Madden RG, Jones C, Fritz M, Gobbi C, Melli G, Pasi E, Herrod J, Lissmann RF, Ashraf HH, Abdelrahim M, Masri OABAL, Fraga M, Benninger D, Kuntzer T, Aubert V, Sahli R, Moradpour D, Blasco-Perrin H, Attarian S, Gérolami R, Colson P, Giordani MT, Hartl J, Pischke S, Lin NX, Mclean BN, Bendall RP, Panning M, Peron JM, Kamar N, Izopet J, Jacobs BC, van Alfen N, van Engelen BGM.

Neurology. 2017 Aug 29;89(9):909-917. doi: 10.1212/WNL.0000000000004297. Epub 2017 Aug 2.

PMID:
28768846
34.

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss Multiple Sclerosis Cohort Study Group.

Ann Neurol. 2017 Jun;81(6):857-870. doi: 10.1002/ana.24954.

35.

Intradiploic encephalocele of the primary motor cortex in an adult patient: electrophysiological implications during surgery.

Valci L, Dalolio M, Kuhlen D, Pravatà E, Gobbi C, Reinert M.

J Neurosurg. 2018 Mar;128(3):871-874. doi: 10.3171/2016.11.JNS162426. Epub 2017 Apr 28.

PMID:
28452617
36.

Video-polysomnographic aspects of painful legs and moving toes syndrome.

Zellini F, Ferri R, Abbafati M, Staedler C, Tiberti M, Gobbi C, Manconi M.

Sleep Med. 2017 May;33:43-46. doi: 10.1016/j.sleep.2017.01.008. Epub 2017 Jan 27. No abstract available.

PMID:
28449904
37.

Efficacious Dorsal Root Ganglion Stimulation for Painful Small Fiber Neuropathy: A Case Report.

Maino P, Koetsier E, Kaelin-Lang A, Gobbi C, Perez R.

Pain Physician. 2017 Mar;20(3):E459-E463.

38.

Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.

Zecca C, Merlini A, Disanto G, Rodegher M, Panicari L, Romeo MAL, Candrian U, Messina MJ, Pravatà E, Moiola L, Stefanin C, Ghezzi A, Perrone P, Patti F, Comi G, Gobbi C, Martinelli V.

Mult Scler. 2018 Feb;24(2):167-174. doi: 10.1177/1352458517694089. Epub 2017 Feb 1.

PMID:
28273776
39.

Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.

Pravatà E, Rocca MA, Valsasina P, Riccitelli GC, Gobbi C, Comi G, Falini A, Filippi M.

Mult Scler. 2017 Dec;23(14):1864-1874. doi: 10.1177/1352458517692886. Epub 2017 Feb 7.

PMID:
28169581
40.

Severe articular and musculoskeletal pain: An unexpected side effect of dimethyl-fumarate therapy for multiple sclerosis.

Bernardini LR, Zecca C, Clerici VT, Gobbi C, Mantegazza R, Rossi S.

J Neurol Sci. 2016 Oct 15;369:139-140. doi: 10.1016/j.jns.2016.07.026. Epub 2016 Jul 14. No abstract available.

PMID:
27653880
41.

[Medium vessel vasculitis in Systemic Lupus Erythematosus].

Maldonado A, Blanzari JN, Asbert P, Albiero JA, Gobbi C, Albiero E, Alba P.

Rev Fac Cien Med Univ Nac Cordoba. 2016;73(1):50-2. Spanish. No abstract available.

PMID:
27419897
42.

[Electrocardiographic changes and QT interval modifications in patients with Early Arthritis].

Alessio D, Gobbi C, Alba P, Asbert P, Albiero E, Salica D, Martinez F.

Rev Fac Cien Med Univ Nac Cordoba. 2016;73(1):27-31. Spanish.

PMID:
27419893
43.

MR neurography of a vagal neuropathy.

Ventura E, Manno C, Gobbi C, Vitale VA, Cianfoni A.

Neurology. 2016 Jul 12;87(2):234-5. doi: 10.1212/WNL.0000000000002838. No abstract available.

PMID:
27402939
44.

Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.

Zecca C, Riccitelli GC, Disanto G, Singh A, Digesu GA, Panicari L, Puccini F, Mattioli M, Tubaro A, Gobbi C.

Eur J Neurol. 2016 Jul;23(7):1228-34. doi: 10.1111/ene.13010. Epub 2016 Apr 27.

PMID:
27120000
45.

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.

Disanto G, Benkert P, Lorscheider J, Mueller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue EW, Sprenger T, Stippich C, Derfuss T, Louvion JF, Kamm CP, Mattle HP, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive PH, Yaldizli Ö, Gobbi C, Kappos L, Kuhle J; SMSC Scientific Board.

PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016.

46.

Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.

Pravatà E, Zecca C, Sestieri C, Caulo M, Riccitelli GC, Rocca MA, Filippi M, Cianfoni A, Gobbi C.

Mult Scler. 2016 Nov;22(13):1665-1675. Epub 2016 Feb 4.

PMID:
26846988
47.

Enhancing clinical decisions about care through a pre-consultation sheet that captures patients' views on their health conditions and treatments: A qualitative study in the field of chronic pain.

Zanini C, Maino P, Möller JC, Gobbi C, Raimondi M, Rubinelli S.

Patient Educ Couns. 2016 May;99(5):747-53. doi: 10.1016/j.pec.2015.11.029. Epub 2015 Dec 3.

PMID:
26673108
48.

Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection--a case report.

Zecca C, Mainetti C, Blum R, Gobbi C.

BMC Neurol. 2015 Dec 2;15:249. doi: 10.1186/s12883-015-0504-0.

49.

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis.

Zecca C, Disanto G, Sormani MP, Riccitelli GC, Cianfoni A, Del Grande F, Pravatà E, Gobbi C.

Mult Scler. 2016 May;22(6):782-91. doi: 10.1177/1352458515599246. Epub 2015 Oct 12.

PMID:
26459149
50.

Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression.

Rocca MA, Pravatà E, Valsasina P, Radaelli M, Colombo B, Vacchi L, Gobbi C, Comi G, Falini A, Filippi M.

Hum Brain Mapp. 2015 Dec;36(12):5051-63. doi: 10.1002/hbm.22992. Epub 2015 Sep 14.

PMID:
26366641

Supplemental Content

Support Center